Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncology Reports|December 18, 2010
Fructose transporter GLUT5 expression in clear renal cell carcinomaV Medina Villaamil, G Aparicio Gallego, L Valbuena Rubira, et al.Molecular Medicine Reports|April 8, 2011
Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parametersLuis M Antón Aparicio, Vanessa Medina Villaamil, Moisés Blanco Calvo, et al.Critical Reviews in Oncology/Hematology|April 19, 2022
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease managementJoaquim Bellmunt, Begoña P Valderrama, Javier Puente, et al.Cancer Genomics & Proteomics|April 8, 2011
Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray studyL M Antón Aparicio, V Medina Villaamil, G Aparicio Gallego, et al.Developmental Cell|March 6, 2007
Notch signaling is essential for ventricular chamber developmentJoaquín Grego-Bessa, Luis Luna-Zurita, Gonzalo del Monte, et al.Expert Opinion on Drug Safety|May 25, 2017
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studiesDaniel Castellano, José Pablo Maroto, Enrique Espinosa, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 15, 2023
Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trialMiguel Ángel Climent, Carlos Álvarez, Rafael Morales, et al.Clinical Genitourinary Cancer|November 18, 2021
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG StudyÁlvaro Pinto, Oscar Reig, Clara Iglesias, et al.Pageof 2